S&P 500   4,970.48 (-0.10%)
DOW   38,529.45 (-0.09%)
QQQ   424.61 (-0.63%)
AAPL   182.42 (+0.47%)
MSFT   399.86 (-0.73%)
META   468.14 (-0.66%)
GOOGL   142.12 (+0.71%)
AMZN   168.48 (+0.84%)
TSLA   194.72 (+0.50%)
NVDA   681.09 (-1.93%)
NIO   6.04 (+1.34%)
AMD   163.16 (-1.53%)
BABA   75.33 (+2.99%)
T   16.92 (+0.06%)
F   12.18 (-0.57%)
MU   80.59 (-0.15%)
CGC   3.37 (-4.80%)
GE   149.06 (+0.30%)
DIS   108.25 (-1.09%)
AMC   4.64 (-0.43%)
PFE   27.40 (-0.69%)
PYPL   58.11 (-0.89%)
XOM   104.23 (+1.44%)
S&P 500   4,970.48 (-0.10%)
DOW   38,529.45 (-0.09%)
QQQ   424.61 (-0.63%)
AAPL   182.42 (+0.47%)
MSFT   399.86 (-0.73%)
META   468.14 (-0.66%)
GOOGL   142.12 (+0.71%)
AMZN   168.48 (+0.84%)
TSLA   194.72 (+0.50%)
NVDA   681.09 (-1.93%)
NIO   6.04 (+1.34%)
AMD   163.16 (-1.53%)
BABA   75.33 (+2.99%)
T   16.92 (+0.06%)
F   12.18 (-0.57%)
MU   80.59 (-0.15%)
CGC   3.37 (-4.80%)
GE   149.06 (+0.30%)
DIS   108.25 (-1.09%)
AMC   4.64 (-0.43%)
PFE   27.40 (-0.69%)
PYPL   58.11 (-0.89%)
XOM   104.23 (+1.44%)
S&P 500   4,970.48 (-0.10%)
DOW   38,529.45 (-0.09%)
QQQ   424.61 (-0.63%)
AAPL   182.42 (+0.47%)
MSFT   399.86 (-0.73%)
META   468.14 (-0.66%)
GOOGL   142.12 (+0.71%)
AMZN   168.48 (+0.84%)
TSLA   194.72 (+0.50%)
NVDA   681.09 (-1.93%)
NIO   6.04 (+1.34%)
AMD   163.16 (-1.53%)
BABA   75.33 (+2.99%)
T   16.92 (+0.06%)
F   12.18 (-0.57%)
MU   80.59 (-0.15%)
CGC   3.37 (-4.80%)
GE   149.06 (+0.30%)
DIS   108.25 (-1.09%)
AMC   4.64 (-0.43%)
PFE   27.40 (-0.69%)
PYPL   58.11 (-0.89%)
XOM   104.23 (+1.44%)
S&P 500   4,970.48 (-0.10%)
DOW   38,529.45 (-0.09%)
QQQ   424.61 (-0.63%)
AAPL   182.42 (+0.47%)
MSFT   399.86 (-0.73%)
META   468.14 (-0.66%)
GOOGL   142.12 (+0.71%)
AMZN   168.48 (+0.84%)
TSLA   194.72 (+0.50%)
NVDA   681.09 (-1.93%)
NIO   6.04 (+1.34%)
AMD   163.16 (-1.53%)
BABA   75.33 (+2.99%)
T   16.92 (+0.06%)
F   12.18 (-0.57%)
MU   80.59 (-0.15%)
CGC   3.37 (-4.80%)
GE   149.06 (+0.30%)
DIS   108.25 (-1.09%)
AMC   4.64 (-0.43%)
PFE   27.40 (-0.69%)
PYPL   58.11 (-0.89%)
XOM   104.23 (+1.44%)

AXIM Biotechnologies (AXIM) News Today

$0.02
+0.00 (+14.81%)
(As of 02/20/2024 05:50 PM ET)
SourceHeadline
finance.yahoo.com logoAXIM® Biotechnologies’ Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation
finance.yahoo.com - February 20 at 9:55 AM
msn.com logoAxim Fishermen Hail Govt
msn.com - February 7 at 11:05 AM
msn.com logoMASLOC Trial: Daniel Axim Denies Charges
msn.com - February 6 at 1:24 PM
msn.com logoAXIM and Auer partner for dry eye disease assay production
msn.com - December 21 at 1:37 PM
finance.yahoo.com logoAXIM® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay Production
finance.yahoo.com - December 20 at 2:01 PM
msn.com logoTullow builds 14-unit dormitory block for Axim Girls SHS
msn.com - December 11 at 10:19 AM
seekingalpha.com logoLLBO Lifeline Biotechnologies, Inc.
seekingalpha.com - December 2 at 12:41 AM
seekingalpha.com logoCollPlant Biotechnologies Ltd. (CLGN) Q3 2023 Earnings Call Transcript
seekingalpha.com - December 2 at 12:41 AM
msn.com logoCourt Orders Mental Test For Axim In MASLOC Trial
msn.com - November 8 at 8:25 AM
msn.com logoAxim Fishermen Plead For More Premix
msn.com - November 1 at 1:07 PM
stockhouse.com logoAXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson's Disease
stockhouse.com - September 12 at 6:45 PM
finance.yahoo.com logoAXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson’s Disease
finance.yahoo.com - September 12 at 6:45 PM
finance.yahoo.com logoAXIM - AXIM Biotechnologies, Inc.
finance.yahoo.com - September 10 at 6:02 PM
finance.yahoo.com logoAXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test
finance.yahoo.com - August 1 at 2:57 PM
finance.yahoo.com logoUpdate: AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
finance.yahoo.com - July 12 at 6:47 PM
finance.yahoo.com logoUpdate: AXIM Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
finance.yahoo.com - July 12 at 6:47 PM
finance.yahoo.com logoAXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
finance.yahoo.com - July 12 at 1:47 PM
markets.businessinsider.com logoNV5's Newly Acquired Subsidiary Axim Pockets Contract From National Geospatial Intelligence Agency
markets.businessinsider.com - June 14 at 3:03 PM
finance.yahoo.com logoAXIM Biotechnologies Announces Over 40 Initial Clinic Commitments for Its Full Diagnostic Assay Platform Launch
finance.yahoo.com - May 24 at 1:54 PM
finance.yahoo.com logoAXIM® Biotechnologies Appoints Kurt Phinney as Chief Operating Officer to Drive Scaling and Optimization of Manufacturing Unit
finance.yahoo.com - May 23 at 9:35 AM
businesswire.com logoiXCells Biotechnologies Expands CRISPR-Cas9 Cell Products and Genome Engineering Services
businesswire.com - May 20 at 11:24 PM
marketwatch.com logoVitiligo Drug Market Analysis and Growth Foresights till 2031
marketwatch.com - May 16 at 9:35 AM
msn.com logoAxim Galamsey Gang Prime Suspect Arrested
msn.com - April 23 at 8:18 PM
finance.yahoo.com logoAXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
finance.yahoo.com - April 11 at 9:54 AM
msn.com logoNzema East MCE assures public of peace, tranquility in Axim
msn.com - April 7 at 6:02 PM
seekingalpha.com logoCollPlant Biotechnologies Ltd. (CLGN) Q4 2022 Earnings Call Transcript
seekingalpha.com - March 31 at 9:37 AM
technews.tmcnet.com logoIntroducing Axim Collaborative and the Appointment of Stephanie Khurana as Chief Executive Officer
technews.tmcnet.com - March 30 at 2:27 PM
msn.com logoAxim Tartan Tracks Ready
msn.com - March 29 at 8:11 PM
nasdaq.com logoAdaptive Biotechnologies Shares Cross Above 200 DMA
nasdaq.com - March 29 at 10:10 AM
msn.com logoAxim Youth Centre Almost Complete
msn.com - March 22 at 9:45 PM
finance.yahoo.com logoMedical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
finance.yahoo.com - March 14 at 10:27 AM
finance.yahoo.com logoAXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical Diagnostic Assay Manufacturing
finance.yahoo.com - March 14 at 10:27 AM
finance.yahoo.com logoAXIM Biotechnologies Files Patent on Fentanyl Neutralizing Antibody Test, Applies for DEA License to Work With Controlled Substance
finance.yahoo.com - January 17 at 2:57 PM
finance.yahoo.com logoAXIM® Biotechnologies CEO Issues Letter to Shareholders; Reminds of Conference Call
finance.yahoo.com - January 11 at 10:09 AM
finance.yahoo.com logoAXIM® Biotechnologies Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnostic Test; Files Provisional Patent
finance.yahoo.com - December 13 at 3:36 PM
finance.yahoo.com logoAXIM Biotechnologies Commercial Partner Verséa Ophthalmics Highlights Benefits of AXIM’s Eye Diagnostic Solutions
finance.yahoo.com - December 6 at 6:35 PM
msn.com logoChief Imam Storms Axim Hometown
msn.com - December 5 at 3:22 PM
finance.yahoo.com logoGlobal Biotechnology / Pharmaceutical Services Outsourcing Market to Reach $86 Billion by 2027
finance.yahoo.com - November 12 at 2:08 PM
marketwatch.com logoAXIM(R) Biotechnologies Receives Initial Order for Diagnostic Solutions as Exclusive Partner Versea Ophthalmics Commences Initial Commercial Launch
marketwatch.com - October 6 at 9:22 AM
finance.yahoo.com logoAXIM® Biotechnologies Receives Initial Order for Diagnostic Solutions as Exclusive Partner Verséa Ophthalmics Commences Initial Commercial Launch
finance.yahoo.com - October 4 at 12:17 PM
finance.yahoo.com logoAXIM® Biotechnologies Point-of-Care Diagnostic Test Platform Sales Commence With Verséa Ophthalmics’ Commercial Launch at AAO 2022
finance.yahoo.com - September 29 at 10:48 AM
finance.yahoo.com logoAXIM® Biotechnologies Signs Exclusive Global Commercialization Agreement With Verséa™ Ophthalmics for Distribution and Sales of Novel Ophthalmic Diagnostics Solutions
finance.yahoo.com - September 19 at 11:17 AM
msn.com logoAxim Mini-Habour 85% Complete
msn.com - September 12 at 11:54 AM
finance.yahoo.com logoMedical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region
finance.yahoo.com - September 8 at 10:08 AM
finance.yahoo.com logoVerséa Holdings, Inc. welcomes Rob Sambursky, MD, as President to lead the company’s expansion into the ophthalmic market
finance.yahoo.com - August 16 at 4:45 PM
benzinga.com logoAxim Biotechnologies (OTC:AXIM), Analyst Ratings, Price Targets, Predictions
benzinga.com - July 26 at 6:04 PM
finance.yahoo.com logoAXIM Biotechnologies Enhances IgE Testing Capabilities; Responds to Global Warming's Impact on Allergy Season
finance.yahoo.com - July 26 at 1:03 PM
stockhouse.com logoAXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20(TM) Podcast
stockhouse.com - July 23 at 7:18 AM
finance.yahoo.com logoAXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast
finance.yahoo.com - July 21 at 9:20 AM
morningstar.com logoAxim Biotechnologies Inc - Stock News
morningstar.com - July 13 at 10:48 PM
Get AXIM Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for AXIM and its competitors with MarketBeat's FREE daily newsletter.



AXIM Media Mentions By Week

AXIM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AXIM
News Sentiment

1.69

0.53

Average
Medical
News Sentiment

AXIM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AXIM Articles
This Week

1

0

AXIM Articles
Average Week

Get AXIM Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for AXIM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:AXIM) was last updated on 2/21/2024 by MarketBeat.com Staff